Enzymatica AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 18.53 million compared to SEK 15.41 million a year ago. Net loss was SEK 13.06 million compared to SEK 6.11 million a year ago. Basic loss per share from continuing operations was SEK 0.08 compared to SEK 0.04 a year ago.
For the nine months, sales was SEK 32.31 million compared to SEK 38.5 million a year ago. Net loss was SEK 46.48 million compared to SEK 34.63 million a year ago. Basic loss per share from continuing operations was SEK 0.31 compared to SEK 0.24 a year ago.